Aravive
developing transformative targeted cancer therapeutics | Aravive
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
39 of 39
Related slides by other companies
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
Fusion Pharmaceuticals
IPO
June 2020
chief scientific james chief medical officer officer fusion lead program targeted alpha therapeutic | Fusion Pharmaceuticals
Revelation Biosciences
Investor Presentation
October 2022
revelation developing innovative therapeutics to address unmet needs | Revelation Biosciences
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights